Home›Companies›Biotech & Pharma›Human Continuum

Human Continuum Inc.

Develops skin care products and treatments for people with joint conditions.

Updated Nov 10, 2026·Latest SEC filing Jun 5, 2026·Suggest an edit

About Human Continuum

Human Continuum is a private company based in Jupiter, Florida, incorporated in 2025 in Nevada. It has reported $3,167,500 raised in two offerings on Form D since June 2026. Its chief executive is Tsun Law.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 29, 2026Jun 5, 2026$2,445,000fully sold64$38,203EquityRule 506(b)Form D ↗
May 29, 2026Jun 5, 2026$722,500fully sold12$60,208EquityRule 506(b)Form D ↗
Total, two offerings$3,167,500

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Human Continuum's Form D filed Jun 5, 2026.

JY
Jiang Yu
President and director
TL
Tsun Law
CEO and Board Member
Also a director at LIST and Nano Nuclear Energy.
Omar Sial
Omar Sial
Chief Scientific Officer

Sources

  1. SECHuman Continuum Inc. filing history
  2. CompanyHuman Continuum privacy policy
  3. CompanyHuman Continuum team